↓ Skip to main content

Small Molecules in Oncology

Overview of attention for book
Attention for Chapter 12: Cabozantinib: A MET, RET, and VEGFR2 Tyrosine Kinase Inhibitor
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Cabozantinib: A MET, RET, and VEGFR2 Tyrosine Kinase Inhibitor
Chapter number 12
Book title
Small Molecules in Oncology
Published in
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2014
DOI 10.1007/978-3-642-54490-3_12
Pubmed ID
Book ISBNs
978-3-64-254489-7, 978-3-64-254490-3
Authors

Carsten Grüllich, Grüllich, Carsten

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 64 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 22%
Researcher 9 14%
Student > Bachelor 9 14%
Student > Master 8 12%
Student > Doctoral Student 4 6%
Other 10 15%
Unknown 11 17%
Readers by discipline Count As %
Medicine and Dentistry 16 25%
Biochemistry, Genetics and Molecular Biology 10 15%
Agricultural and Biological Sciences 5 8%
Immunology and Microbiology 4 6%
Chemistry 3 5%
Other 6 9%
Unknown 21 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2018.
All research outputs
#7,554,540
of 23,045,021 outputs
Outputs from Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer
#55
of 172 outputs
Outputs of similar age
#92,702
of 306,691 outputs
Outputs of similar age from Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer
#5
of 11 outputs
Altmetric has tracked 23,045,021 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 172 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,691 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.